Novo Nordisk A/S
Obesity drugs’ popularity put a dent in these stocks. Why analysts say they’re still worth buying
Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won’t hurt the demand for insulin pumps and continuous glucose monitors, but most investors aren’t buying it. Medical device stocks have been falling session after session, prompting UBS analyst Danielle Antalffy on Wednesday to lower her price targets for Dexcom and a […]
Read More
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
Weight loss drugs are being assessed for their ability to treat conditions like dementia and addiction after a landmark study showed that Wegovy helped reduce the risk of heart attacks and strokes. Bloomberg | Bloomberg | Getty Images LONDON — Scientists have begun investigating whether so-called miracle obesity drugs could be used to treat conditions […]
Read More
Novo Nordisk’s Wegovy weight loss drug launches in the Uk
Offers of the weight-loss drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy. Stefan Trumpf | Photo Alliance | Getty Photographs Novo Nordisk introduced its Wegovy pounds decline injection in the U.K. on Monday, advancing the drug’s rollout in Europe regardless of ongoing source constraints. The Danish […]
Read More
‘Robot pills’ could one day help patients avoid needles. The stocks are cheap, but risky
Ask most patients if they prefer to receive medicine by swallowing a pill, by injection or infusion, and most will likely opt for the pill. But that’s not always possible for drugs that use delicate molecules that can’t tolerate the physical and chemical conditions in the gastrointestinal tract. That’s where a number of early-stage drug […]
Read More
Weight loss drugmaker Novo Nordisk vies to come to be Europe’s most valuable enterprise, toppling LVMH
Denmark’s Novo Nordisk on Friday briefly overtook French luxurious merchandise behemoth LVMH to turn into Europe’s most precious corporation as traders wager on the opportunity of its pounds decline drugs. Novo Nordisk’s sector capitalization was $421 billion like unlisted stock at 9:43 a.m. London time, according to Refinitiv information cited by Reuters, vs . LVMH’s […]
Read More
Ozempic could be the next target of Medicare drug price negotiations – here’s why
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Ozempic, the blockbuster diabetes treatment from Novo Nordisk, could be next in line for price negotiations between manufacturers and Medicare. […]
Read More
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans. President Joe Biden’s Inflation Reduction Act, which passed in a […]
Read More
Wegovy helps reduce heart failure symptoms in obese people, study says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Wegovy, the popular weight loss drug from Novo Nordisk, significantly reduced symptoms of a common type of heart failure in patients with obesity, according to a late-stage clinical […]
Read More
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Drugmakers aren’t the only ones feeling the impact of the weight loss industry gold rush. Retailers with pharmacy businesses, such […]
Read More
Here are some of the companies saying weight loss drugs could impact their business
The impact of new weight loss treatments is being felt well beyond the health-care industry . Analysts used the ritual of quarterly earnings calls to probe companies on whether their businesses were being helped — or hampered by — the latest trend. Drugs that mimic gut hormones like glucagon-like peptide-1, or GLP-1, were first used […]
Read More